Reuters logo
Spark to announce gene therapy price in January
December 19, 2017 / 4:18 PM / a month ago

Spark to announce gene therapy price in January

NEW YORK, Dec 19 (Reuters) - Spark Therapeutics will announce the price for its gene therapy for inherited blindness, Luxturna, which was approved on Tuesday by U.S. regulators, in early January, a Spark spokeswoman said by email.

Luxturna is expected to be available late in the first quarter of 2018, she said. (Reporting by Caroline Humer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below